{
    "N/R/U": null,
    "Applicant": "Emergent BioSolutions Canada Inc.",
    "BLA Number": "125562",
    "Proprietary Name": "Anthrasil",
    "Proper Name": "Anthrax Immune Globulin Intravenous (Human)",
    "BLA Type": "351(a)",
    "Strength": ">=60 U",
    "Dosage Form": "Injection",
    "Route of Administration": "Intravenous",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "March 24, 2015",
    "Ref. Product Proper Name": " ",
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "2084",
    "Product Number": "001",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": "March 24, 2022"
}